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Background & Objective: To study the immunophenotype of prostate cancer (PC) with 
the presence and absence of intraluminal inclusions (IIn), depending on the grade score.  
Methods: A total of 30 PC samples with IIn (group E) and 30 PC samples without them 
(group C) were studied. These groups were divided into 2 subgroups, depending on the 
grade of malignancy, which was determined according to the Gleason score as moderate 
and high-grade tumors. Macroscopic analysis, hematoxylin-eosin staining, 
immunohistochemistry (androgen receptors, p53 and Bax proteins, Hsp70 and Hsp90, 
CD68, VEGF, OSN, MMP-1) were used. 
Results: The expression level of VEGF was higher in the more differentiated tumors of 
the control group (P<0.01). Increased expression of prognostic-adverse markers p53 (in 
the presence of IIn, P<0.01) and MMP-1 (P<0.05) was observed. Also, a higher level of 
OSN expression was found in PC tissue with IIn (P<0.01) due to its participation in the 
processes of biomineralization. The expression level of CD68 and Bax protein was higher 
in the PC group with IIn (both P<0.01). Furthermore, Hsp90 had a significantly lower 
expression level in the PC of group E (P<0.05).  
Conclusion: the presence of IIn in the PC samples of group E promotes tissue remodeling 
with mechanical trauma, chronic inflammation, and fibrosis development. The presence 
of IIn in PC leads to the increase of OSN, CD68 and Bax expression and decrease of 
Hsp90 and VEGF expression. High expression of p53 and MMP-1 and low expression of 
OSN and VEGF was identified as a characteristic of high-grade tumors. 
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Introduction 
Prostate cancer (PC) is one of the most common 
causes of cancer-related deaths all over the world. 
According to the American Cancer Society, in 2010-
2014 PC incidence and mortality rates were 118.2 and 
19.5 cases per 100.000, respectively (1). The PC 
development and progression are closely related to the 
presence of chronic inflammation, which is associated 
with the presence of intraluminal inclusions (IIn) 
(prostatic calculi and amyloid corpuscles, or corpora 
amylacea) (2). The presence of IIn is also associated 
with an increased number of CD68 positive activated 
macrophages, the development of chronic pelvic pain 
syndrome and PC (3-4). Formation of IIn is a complex 
process, which involves the interaction of both tumor 
cells and tumor stroma. The remodeling of stromal 
components is manifested by the angiogenesis (the 
appearance of VEGF-positive cells) and the expression 
of stress tissue factors (Hsp70 and Hsp90), which have 
a tumorigenic effect and promote the development of 
bone metastases (5-6). Destruction of connective tissue 
(due to increased expression of MMP-1) causes 
migration and invasion of cancer cells, and this results in 
the development of the metastatic PC (7). Progression of 
PC is accompanied by increased levels of apoptosis 
(expression of the mutant p53 protein and Bax protein) 
and changes in sensitivity to androgens (decreased 
expression of receptors to androgens) (8,9).  
The course and prognosis of the malignant process is 
directly related to the grade score of the tumor tissue. The 
Gleason grading system is generally accepted to estimate 
the morphological status of PC (10). It has been shown 
that prognosis of the disease deteriorates and probability 
of metastasis (predominantly to the bones) increases 
significantly with increasing of PC grade score (11). 
The aim of this study is to evaluate the immune-
histochemical phenotype of prostate cancer with the 
presence and absence of intraluminal inclusions, 
depending on the grade score.  
Materials and Methods 
Samples of Prostate Cancer 
The study was conducted on the biopsy material 
obtained during surgeries at the Sumy Regional Clinical 
Hospital and Sumy City Clinical Hospital 1. The selected 
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PC samples were divided into two groups according to the 
presence/absence of IIn. In total, 30 PC samples with 
inclusions (experimental group, E) and 30 PC samples 
without inclusions (control group, C) were studied. The 
control and experimental groups were divided into 2 
subgroups, depending on the grade score, which was 
determined according to the Gleason grading system: 
tumors with a moderate (C2 and E2) and high (C3 and E3) 
grade score. The groups C2 and E2 included tumors with 
7-8 Gleason scores (class 2-4) and the groups C3 and E3 
included tumors with 9-10 Gleason scores (class 5) (10). 
The Ethics Commission 
This study was approved by the ethics committee of 
the Medical Institute of Sumy State University 
(Proceedings 3/6; June 7, 2016). 
Histology  
Biological material was fixed in 10% neutral buffer 
formalin solution for 24 hours. Subsequently, the material 
was dehydrated and paraffin embedded. Paraffin series 
were sliced at a thickness of 4 μm on a rotational 
microtome Shandon Finnesse 325 (Thermo Scientific, 
USA). Deparaffinized and rehydrated sections were 
stained with hematoxylin and eosin.  
Immunohistochemistry (IHC) 
In summary, 4 µm-thick serial sections made from 
prepared paraffin blocks were applied to SuperFrost 
adhesive slides (Thermo Scientific, USA). The 
deparaffinized sections were subjected to demasking of 
the antigens by thermal treatment in citrate buffer (pH 6.0) 
at a temperature of 95-98°C. The UltraVision Quanto 
Detection System HRP Polymer (Thermo Scientific, 
USA) detection system was used for visualization of 
results. It includes reduction of the endogenous 
peroxidase activity with 3% hydrogen peroxide, blocking 
of non-specific background reaction with the "Ultra V 
Block", and enhancing with the "Primary Antibody 
Amplifier Quanto". Diaminobenzidine (DAB) was used 
as a chromogen. The following antibody panel was used 
(Thermo Scientific, USA): androgen receptors (AR), pro-
apoptotic protein Bax and protein p53 (p53), matrix 
metalloproteinase 1 (MMP-1), vascular endothelial 
growth factor (VEGF), heat shock protein 86 kDa 
(Hsp90), heat shock protein of 70 kDa (Hsp70), CD68, 
and osteonectin (OSN) (Table 1).
 
Table1. Antibody panel for IHC 
Antibody Immunized Animal Clone Dilution Expression pattern 
AR Rabbit Polyclone 1:200 Nucleus 
р53 Mouse SP5 1:100 Nucleus 
MMP-1 Rabbit Polyclone 1:50 Cytoplasm 
VEGF Rabbit Polyclone 1:200 Cytoplasm and membrane 
Hsp90 Rabbit Polyclone 1:100 Nucleus and cytoplasm 
Hsp70 Rabbit Polyclone 1:100 Nucleus and cytoplasm 
Bax Rabbit Polyclone 1:100 Cytoplasm 
CD68 Mouse KP1 1:100 Cytoplasm 
OSN Rabbit Polyclone 1:50 Cytoplasm 
 
Morphometric study was conducted using the 
morphometric programs "SEO Scan ICH 285 AK-F 
IEE-1394" (Ukraine) and "Zen 2.0" (Carl Zeiss, 
Germany). The number of positive tumor cells was 
counted in fields with a diameter of 1000 μm. 
Photographing and storage of images were conducted 
using the digital imaging systems "SEO Scan ICH 285 
AK-F IEE-1394" (Ukraine) and "ZEN" for Carl Zeiss 
microscopes (Germany). We used active (tissue with 
established positive and negative reactions) and 
passive control of results. 
Statistical Analysis 
The normality of all data sets was assessed by the 
Shapiro-Wilk test. In case of an abnormal distribution, 
a nonparametric method, the Mann-Whitney test, was 
used. In case of correct distribution, the data were 
compared using parametric Student’s t-test to 
determine the reliability of the difference. The results 
were considered statistically significant with a 
probability of more than 95% (P<0.05). The graphical 
representation of statistical analysis results was 
performed using the GraphPad Prism 7.04.  
Results 
Histological Structure of Tumor Tissue 
Histological analysis of the PC tissue of the 
experimental group with a moderate grade score (E2) 
showed the presence of glands, which were formed by 
atypical cells (Figs. 1a and 1b). These cells had 
hyperchromic nuclei, and the crybroid and 
pseudotrabecular structures were present. Well-
developed stromal component was observed between 
tumor glands. Most glands had a lumen and were located 
close to each other. 
214 Prostate Cancer with Intraluminal Inclusions 
Vol.14 No.3 Summer 2019                                                                                     IRANIAN JOURNAL OF PATHOLOGY 
The PCs of group E3 were characterized by a 
significant violation of histological structure and 
simplification of tumor glands. These glands formed 
multiple chains and nests. Tissue of the tumors had a 
small amount of the stromal components (Figs. 2a and 
2b). Most of the glands did not have a lumen. In addition, 
in majority of cases, the samples of this group were 
represented only by the tumor field. 
Samples of the experimental group (E2 and E3) were 
characterized by the presence of IIn in the tumor glands. 
These inclusions were round-formed and repeated the 
shape of gland lumen. Prostatic calculi were 
characterized by dark brown color and a more 
homogeneous structure. Corpora amylacea had a layered 
structure and a dark pink color. 
The tissue samples of both experimental and control 
groups had the inflammatory infiltration around tumor 
glands. However, the severity of the inflammatory 
process was higher in the experimental group. 
Inflammatory infiltration consisted mainly of 
macrophage cells, lymphocytes, and neutrophils (Figs. 
1a, 1b, 2a, 2b, 3a, 3b, 4a and 4b). 
IHC Characteristic of Tumor Tissue 
IHC examination of AR expression in the PC tissue 
of subgroups E2 and E3 showed a clear nuclear reaction 
in tumor cells and in single cells of the peripheral tumor 
stroma (Figs. 1c, 1d, 2c, 2d and 6). The number of 
positive cells for the subgroup E2 corresponded to 
396.79±26.02, and this number was 360.91±36.87 tumor 
cells for the subgroup E3 in the view field. The number 
of positive nuclei was 417.17±39.61 and 424.88±53.76 
cells in the view field for samples of subgroups C2 and 
C3, respectively (Figs. 3c, 3d, 4c, 4d and 6).
 
Figure 1. IHC examination of PC in subgroup E2: A-B – staining with hematoxylin and eosin; C-D – IHC detection of AR; 
E-F - IHC identification of p53 protein; G-H – IHC detection of p53; I-J – IHC of OSN expression; K-L – IHC detection of 
Hsp70; M-N – IHC detection of Hsp90; O-P – IHC detection of VEGF; Q-R – IHC detection of MMP-1; S-T – IHC detection of 
CD68+ positive cells. Chromogen – diaminobenzidine. Nuclei were counterstained with Mayer’s hematoxylin. The 
magnification is indicated in the lower right corner of each image. 
The expression level of p53 protein in tumor tissue 
samples of subgroups E2 and E3 was 33.09 ± 3.3 and 
46.7±2.15 cells in the view field, respectively (Fig. 1e, 
1f, 2e, 2f and 6). The staining had a nuclear nature and 
positive cells were placed mainly in small groups. 
Moreover, 30.49±2.96 and 42.48 ± 3.36 tumor cells in 
the view field were detected in PC of subgroups C2 and 
C3, respectively (Figs. 3e, 3f, 4e, 4f and 6). 
Pro-apoptotic Bax protein had a cytoplasmic nature 
of expression and moderate signal intensity. In PC 
samples of the subgroups E2 and E3, a total of 65.18 ± 
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3.53 and 58.05±3.79 positive cells were identified, 
respectively (Fig. 1g, 1h, 2g, 2h and 6). Meanwhile, the 
levels of expression corresponded to 42.69 ± 3.64 and 
46.54±4.68 tumor cells in the view field in the 
subgroups C2 and C3, respectively (Fig. 3g, 3h, 4g, 4h 
and 6).
 
Figure 2. IHC examination of PC in subgroup E3: A-B – staining with hematoxylin and eosin; C-D – IHC detection of AR; 
E-F - IHC identification of p53 protein; G-H – IHC detection of p53; I-J – IHC of OSN expression; K-L – IHC detection of 
Hsp70; M-N – IHC detection of Hsp90; O-P – IHC detection of VEGF; Q-R – IHC detection of MMP-1; S-T – IHC detection of 
CD68+ positive cells. Chromogen – diaminobenzidine. Nuclei were counterstained with Mayer’s hematoxylin. The 
magnification is indicated in the lower right corner of each image. 
Hsp70 had a mixed nuclear-cytoplasmic nature of 
expression. The number of Hsp70-positive tumor cells 
in the tissues of subgroups E2 and E3 was 325.57±20.53 
and 298.56 ± 17.19 cells, respectively (Fig. 1k, 1l, 2k, 2l 
and 6). In addition, the number of positive tumor cells in 
subgroups C2 and C3 was 274.73±32.72 and 
260.72±17.7, respectively (Figs. 3k, 3l, 4k, 4l and 6). 
During the IHC examination of the Hsp90, its 
expression was detected in the nucleus and cytoplasm of 
neoplastic cells. The number of positive elements was 
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352.84±26.39 in the subgroup E2 and 331.28 ± 28.5 in 
the subgroup E3 (Figs. 1m, 1n, 2m, 2n and 6). For 
subgroups C2 and C3, these levels corresponded to 
413.3±39.66 and 454.98±17.42 cells (Figs. 3m, 3n, 4m, 
4n and 6); also, its presence was detected between the 
corpora amylacea layers and the stagnant gland 
secretion. 
VEGF had the cytoplasmic nature of the expression 
in the form of grains and lumps. In subgroups E2 and E3, 
the number of VEGF-positive tumor cells was 
50.65±3.91 and 50.97±2.86, respectively (Figs. 1o, 1p, 
2o, 2p and 6). The tumor tissue of subgroups C2 and C3 
showed 68.84±4.8 and 54.08±2.09 positive neoplastic 
cells, respectively (Figs. 3o, 3p, 4o, 4p and 6). 
 
Figure 3. IHC examination of PC in subgroup C2: A-B – staining with hematoxylin and eosin; C-D – IHC detection of AR; 
E-F - IHC identification of p53 protein; G-H – IHC detection of p53; I-J – IHC of OSN expression; K-L – IHC detection of 
Hsp70; M-N – IHC detection of Hsp90; O-P – IHC detection of VEGF; Q-R – IHC detection of MMP-1; S-T – IHC detection of 
CD68+ positive cells. Chromogen – diaminobenzidine. Nuclei were counterstained with Mayer’s hematoxylin. The 
magnification is indicated in the lower right corner of each image. 
MMPI-1 was detected in the form of diffuse 
cytoplasmic expression. It was expressed in the both 
tumor and stromal components of PC. The number of 
positive tumor cells was 32.49 ± 1.6 and 43.92±1.82 in 
the tissues of subgroups E2 and E3, respectively (Fig. 
1q, 1r, 2q, 2r and 6). In subgroups C2 and C3, 
32.54±2.46 and 41.13±2.45 MMP1-positive cells were 
detected, respectively (Figs. 3q, 3r, 4q, 4r and 6). 
CD68 had a cytoplasmic nature of expression. In 
tumor tissue and stroma of subgroups E2 and E3, a total 
of 138.11±5.57 and 136.86±4.05 CD68-positive cells 
were detected (Fig. 1s, 1t, 2s, 2t and 6); this number was 
85.6±5.22 and 98.7 ± 6.09 positive cells for subgroups 
C2 and C3, respectively (Figs. 3s, 3t, 4s, 4t and 6). 
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Figure 4. IHC examination of PC in subgroup C3: A-B – staining with hematoxylin and eosin; C-D – IHC detection of AR; 
E-F - IHC identification of p53 protein; G-H – IHC detection of p53; I-J – IHC of OSN expression; K-L – IHC detection of 
Hsp70; M-N – IHC detection of Hsp90; O-P – IHC detection of VEGF; Q-R – IHC detection of MMP-1; S-T – IHC detection of 
CD68+ positive cells. Chromogen – diaminobenzidine. Nuclei were counterstained with Mayer’s hematoxylin. The 
magnification is indicated in the lower right corner of each image. 
The glycoprotein OSN had a diffuse cytoplasmic 
expression in tumor cells. The PC samples of 
subgroups E2 and E3 had 102.03±5.05 and 53.11±4.59 
positive tumor cells, respectively (Figs. 1i, 1j, 2i, 2j and 
6). Furthermore, subgroups C2 and C3 had a total of 
43.1±3.44 and 30.5±2.88 OSN-positive neoplastic 
cells, respectively (Figs. 3i, 3j, 4i, 4j and 6). 
The expression of the markers in groups E and C 
are presented in figure 5.
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Figure 5. Mean values of AR, p53, VEGF, OSN, Hsp90, Hsp70, MMP-1, CD68, and Вах expression in the PC tissues. * – 
P<0.05, *** – P<0.001. 
 
 
Figure 6. Statistical analysis of AR, p53, MMP-1, VEGF, Hsp70, Hsp90, Bax, CD68, and OSN expression in the 
experimental and control groups of PC tissues, depending on the grade score. The column indicates the mean value; the bar – 
95% confidence interval, * – significant difference (P<0.05).
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Discussion 
The average age of patients with PC in experimental 
and control groups was 70.23 ± 1.71 and 68.27 ± 1.27 
years (P> 0.05), respectively. All PC samples were 
represented by acinar adenocarcinoma.  
During morphological examination of the PC tissue 
in the experimental group, prostate tissue structural 
transformation was manifested with cystic expansion of 
the glands, a retention of secretion, associated with the 
presence of IIn of amyloid and mineral nature. There 
were also the signs of chronic inflammation, mechanical 
injury of the glands epithelial component, the presence 
of cellular detritus in the lumen, glands micro-fractures 
and deformation (12). Also, fibrotic fibers growth, 
isolated hemorrhages, and moderate edema in the 
surrounding tissues were observed. 
The neoplastic tissue of the control group samples 
was characterized by the IIn absence. This caused a 
decrease of the stagnant phenomena in the glands and 
ducts, and reduced the glandular epithelium 
traumatization. These changes led to a low intensity of 
inflammatory reaction in the PC tissue (13). 
PC samples of E2 subgroup were characterized by a 
distinct structure of the epithelial component with the 
formation of well-recognized glands and 
pseudoglandular structures, by the production and 
accumulation of secretion. Secondary changes were not 
significant in tumor tissue. 
Subgroup E3 was presented by PC tissue samples 
with a simplified structure of neoplastic tissue. Cancer 
cells were located in the form of unorganized mass, 
nests, chains, layers, and single cells. The simplicity of 
PC tumor tissue manifested with the monomorphic 
structure of tumor cells with significant decrease of 
glandular structures. The presence of secondary changes 
as necrosis, mucinous transformation, and hemorrhages 
were observed. 
The characteristics of the PC samples of subgroup 
C2 included: maturity of atypical glandular structures, 
IIn absence, and secretion stagnation in the glandular-
duct system. The structure of PC samples of subgroup 
C3 corresponded to the morphological structure of 
subgroup E3 (except the IIn presence and the 
inflammatory infiltration intensity). 
During the IHC study of the androgens effect on the 
PC tissues, both groups showed a high sensitivity to 
these hormones in the absolute majority of the studied 
samples (1 sample with a negative reaction in the 
subgroup E3 was detected). There was no significant 
difference between AR expression of the groups (Fig. 5 
and 6). In a previous study, the correlation between AR 
expression and functional activity of the neoplastic 
tissue and grade score was noted (14). However, our 
analysis of the influence of tumor grade score on the AR 
expression level indicated the absence of any significant 
difference in the rates of experimental and control 
groups. According to James L. Mohler (2008), changes 
in the genes encoding the androgen receptors, as well as 
the conformational changes in the structure of the AR 
itself, have a limited role in the PC progression and 
castration-resistant PC development. It was also found 
that the expression of androgen receptors does not 
depend on the grade score of tumor (15).  
System of pro-apoptotic proteins p53 and Bax has an 
important role in apoptotic processes. The p53-
dependent apoptosis of the cells occurs indirectly by 
activating the Bax protein (Bcl-2 protein family) (16). 
The significant difference of p53 expression was found 
in subgroups E2 and E3 with a higher activity in high-
grade PC (Fig. 6). These results may indicate a great 
dependence between the p53 expression and grade 
score, and a low correlation of this parameter with the 
presence of IIn. These results are in full agreement with 
the findings of the study conducted by Thomas DJ et al. 
(1993), in which they found that high expression of p53 
is inherent predominantly for high-grade tumors and is 
accompanied by a deterioration in the prognosis of the 
disease and reduced patients life expectancy (17).  
Bax expression analysis demonstrated a significant 
difference between the experimental and control groups. 
But there was no statistically significant difference in the 
results of the IHC reaction between subgroups E2 and 
E3, as well as C2 and C3. This suggests that IIn stimulate 
the pro-apoptotic proteins formation and promote 
apoptosis, while the role of the grade score in the Bax 
expression was not proven (Fig. 5). However, Li-Yan 
Khor (2006) indicated the direct dependency of the Bax 
expression to the Gleason score and prognosis and 
concluded that more aggressive or high-grade tumors  
have an increased Bax expression (18-19).  
The role of the Hsp70 and Hsp90 in the apoptosis 
inhibition has been proven. These proteins inhibit the 
activity of pro-apoptotic proteins (in particular, 
caspases) (20). In our study, a statistically significant 
difference was found between the expression of Hsp90 
in the experimental and control groups (Fig. 5). The 
presence of Hsp90 in the structure of corpora amylacea 
was detected due to their probable participation in the 
formation of these inclusions. No correlation was found 
between the grade score and Hsp90 expression (Fig. 6). 
During the study of the Hsp70 expression, there was no 
significant difference between the experimental and 
control groups, subgroups E2 and E3, and C2 and C3. 
However, there was a tendency toward their increase in 
PC with the presence of IIn. This suggests that neither 
the PC grade score nor the presence of IIn can influence 
the expression of Hsp70 (Fig. 5 and 6). Although 
majority of studies point to the insignificant role of high-
molecular heat shock proteins in the processes of 
tumorigenesis (21), their association with the risk of 
metastatic breast cancer development was found (22). 
There is also a link between the p53 and Hsp70 (inhibits 
the caspase-9-dependent mitochondrial apoptosis, 
stabilizes the structure of the mutant p53 protein, and 
stimulates cell proliferation). Hsp70 is associated with a 
more aggressive course of the disease and is an adverse 
prognostic factor (23). Meanwhile, the dependence of 
the Hsp90 expression on the presence of IIn is 
220 Prostate Cancer with Intraluminal Inclusions 
Vol.14 No.3 Summer 2019                                                                                     IRANIAN JOURNAL OF PATHOLOGY 
unexplored. However, it has been found that elevated 
levels of extracellular Hsp90 increase cellular migration, 
invasive potential of PC models, and tumorigenicity 
(24).  
Expression of MMP-1 is associated with a tumor 
invasion and development of metastases. That is why the 
expression of MMP-1 in tumor tissue is considered as 
unfavorable factor for PC prognosis. (25). There was no 
statistically significant difference between the 
experimental and control groups during the IHC analysis 
(Fig. 5). However, we detected the effect of PC grade 
score on the MMP-1 expression in both experimental 
and control groups. Moreover, a significantly higher 
MMP-1 expression was found in the high-grade PC (E3 
and C3) (Fig. 6). These findings are supported by the 
results of Zhong et al. (2008), in which they indicated 
the correlation between the expression of MMP-1 and 
the disease stage (26). MMP-1, or collagenase 1, is 
involved in the destruction of the connective tissue 
component of the tumor stroma and creates conditions 
for the development of PC metastases (27). Higher 
levels of MMP-1 expression in high-grade tumors of 
both groups can be explained by this phenomenon. 
Increased expression of VEGF by tumor tissue is 
considered to be a prognostic-adverse factor (28). Our 
results indicated a significantly higher expression of 
VEGF in the control group (Fig. 5). The prevalence of 
expression in subgroup C2 was found in comparison to 
subgroup C3. This may indicate a negative influence of 
IIn on tumor tissue vascularization processes. However, 
most studies indicate an increased VEGF expression in  
high-grade tumors (29-30).  
We used IHC for the evaluation of CD68 expression 
to determine the number of macrophage cells. A 
significantly higher number of CD68-positive cells was 
found in the experimental group (Fig. 5). There was no 
difference in the number of CD68-positive cells in 
tumors with a different grade score. This indicates that 
the grade score does not influence the infiltration of 
tumor tissue by macrophages. M. Lanciotti et al. (2014) 
found that the increased number of tumor activated 
macrophages is associated with the extracapsular 
extension and progression of PC (31). Thus, the 
significant number of the mononuclear phagocyte cells 
in PC tissues of experimental group indicates the role of 
IIn in the chronic inflammation development.  
OSN is involved in the processes of biomine-
ralization and remodeling of the extracellular matrix; 
and it may be a tumor growth inhibitor. Its level of 
expression depends on the grade score of the epithelial 
and stromal components of various tumor types (32). 
During the study, we found a significantly higher level 
of OSN expression in the PC samples of the 
experimental group (Fig. 5). This may be stipulated by 
his participation in the prostatic calculi formation and 
growth. There was also a predominance of OSN 
expression in the moderate-grade PC tissues of both 
groups (P<0.05) (Fig. 6). According to K. Jacob et al. 
(1999), OSN specifically enhances the activity of matrix 
metalloproteinases and promotes the migration of PC 
cells and the development of bone metastases (33). 
Therefore, we suggest that increased OSN expression is 
associated with the presence of IIn and increased 
expression of MMP-1. The combination of these factors 
contributes to the development of metastases. 
Conclusion 
The presence of IIn in the PC tissues of experimental 
group promotes tissue remodeling with a violation of the 
glands’ secretory cycle and drainage function. These 
changes lead to mechanical traumatism, chronic 
inflammation development, and fibrosis. 
In the PC samples, a high AR expression was 
detected, which did not depend on the grade score and 
the presence of IIn. 
The level of VEGF expression was higher in low-
grade PC with IIn. This may indicate a suppressive effect 
of IIn on the vascularization of tumor tissue. The 
significance of this phenomenon is unclear and requires 
further research. 
With a decrease in the grade score of PC, expression 
level of prognostic-adverse markers p53 (in the case of 
the IIn presence) and MMP-1 increases. 
The OSN expression is higher in PC tissues with IIn 
due to its participation in the processes of biomine-
ralization. Meanwhile, the expression of this 
glycoprotein is lower in the high-grade PC. 
The number of CD68-positive and Bax-positive cells 
is significantly higher in the PC with IIn. This may be 
determined by physical injuries of the epithelium and 
surrounding tissues with the development of chronic 
inflammation. 
The Hsp90 has a significantly lower expression in 
the PC tissues with IIn, which may be determined by its 
deposition in the structure of corpora amylacea. 
Expression of the Hsp70 was independent of the 
presence of IIn and on the PC grade score. 
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